Skip to main content
. 2008 Jan 29;23(5):509–516. doi: 10.1007/s11606-008-0515-2

Table 2.

Cost of Care during ALLHAT and Estimated Lifetime Cost

  Mean cost chlorthalidone Increase in cost (95%CI) versus chlorthalidone
Amlodipine Lisinopril
In trial
  Drug cost ($)
   Study drug 618 2,681 (2,649, 2,714) 1,383 (1,360, 1,405)
   Other antihypertensive drug 1,168 17 (−15, 48) 241 (209, 277)
   Total drug cost 1,786 2,698 (2,631, 2,762) 1,624 (1,586, 1,664)
Hospitalization ($)
  Heart failure 368 68 (20, 123) 18 (−34, 71)
  Ischemic heart disease 1,876 58 (−95, 216) 87 (−67, 253)
  Stroke 240 −3 (−45, 37) 54 (6, 100)
  Other cardiovascular 988 1 (−101, 101) 50 (−47, 148)
  Cancer 1,069 26 (−67, 113) 225 (130, 307)
  Other noncardiovascular 4,063 −320 (−558, −40) 138 (−150, 449)
Total hospitalization cost 8,604 −170 (−535, 235) 572 (150, 1038)
Outpatient visit cost ($) 1,057 −9 (−34, 15) 28 (−3, 57)
Total in trial cost ($) 11,447 2,519 (2,154, 2,934) 2,224 (1,797, 2,692)
Lifetime cost ($) 53,536 4,802 (3,862, 6,092) 3,700 (2,676, 5,000)

Cost of care discounted at 3% per year. Individual costs may not sum to totals as a result of rounding.